ASN95 -- Selected abstracts: Hypertension
Sun. Nov. 5 1995
9:30 A.M. ---Poster--- San Diego
Conv Ctr Halls A and B
Mechanisms of progression
Program number 99 Board# S99 at 10:45 A.M.
Non-insulin dependent diabetes with low-renin hypertension: Renal
responses to ACE-inhibition.
J.M. de Oliveira, D.A.
Price, N.D.L. Fisher and N.K. Hollenberg. - Boston,
MA.
9:30 A.M.
---Poster--- San Diego Conv Ctr Halls A and B
Clinical
transplantation II
Program number 381 Board# S381 at 10:45 A.M.
In
kidney transplanted patients developing graft renal artery stenosis
erythrosis appears before
blood pressure increases. H. Mazouz, P.F. Westeel, P. Hue, M.A.
Pietri, M.
Bouzernidj, A.C. Gauvin, J. Petit and
A. Fournier.- Amiens, France.
9:30 A.M.
---Poster--- San Diego Conv Ctr
Halls A and B
Diabetes mellitus
Program number 445 Board# S445 at 10:45 A.M.
The dopaminuric
response to high salt diet is attenuated both in insulin-dependent
diabetes and in offspring of
borderline hypertensive parents. S. Rudberg, C. Lemne, B. Persson,
A. Krekula, U. De
Faire and A. Aperia. -
Stockholm, Sweden.
Program number 448 Board# S448 at 10:45 A.M.
Erythrocyte Na+/Li+ and Na+/H+ countertransports in hypertensive NIDDM
subjects. The effects of
insulin and anti-H treatment.
M. Giordano, M. Canessa, P. Castellino and R.A. Defronzo. -
San Antonio, TX.
9:30 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Nitric oxide and hypertension
Program number 514 Board# S514 at 10:45 A.M.
Cyclosporine A-induced salt sensitive hypertension: Role of nitric
oxide. e.J. Wang,
P.J. Shultz and J.P. Tolins.
- Minneapolis, MN.
Program number 515 Board# S515 at 10:45 A.M.
Microalbuminuria and the renal vascular response to l-arginine in
essential
hypertension. A.
Mimran, J. Ribstein, J-M. Halimi and G. Ducailar. -
Montpellier, France.
9:30 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Myocytes/vascular smooth muscle cells
Program number 612 Board# S612 at 10:45 A.M.
Gene expression in uremic left ventricular hypertrophy: Effects of
hypertension and
anemia. Y.K. Pak,
A.Daraksharapu, S.L. Chang, P.S. Kim and R.H.K. Mak. -
Stanford, CA.
Mon. Nov. 6 1995
9:00 A.M. ---Poster--- San Diego Conv Ctr
Halls A and B
Hypertension: Clinical I
Program number 769 Board# M38 at 10:00 A.M.
Increased carotid artery thickness in salt-sensitive hypertensives.
R. Bigazzi,
S. Bianchi, R. Nenci and V.M.
Campese.- Livorno, Italy and Los Angeles, CA.
Program number 770 Board# M39 at 10:00 A.M.
Suppressible aldosterone production in aldosteronomas.
E.L. Bravo. -
Cleveland, OH.
Program number 771 Board# M40 at 10:00 A.M.
Effect of
an acute saline load on cytosolic Ca2+i in platelets of salt-sensitive
patients with
hypertension. H-Y. Chang,
S. Bianchi, M. Tawadrous and V.M. Campese. - Los
Angeles, CA.
Program number 772 Board# M41 at 10:00 A.M.
Differential effects of monounsaturated fat and high carbohydrate
diet-induced weight loss on insulin
secretion and blood pressure. E.B. Grossman, C.C. Low and B.
Gumbiner. -
Rochester, NY.
Program number 773 Board# M42 at 10:00 A.M.
Losartan reduces
albuminuria in patients with essential hypertension. An enalapril
controlled 3 months
study. S.Nielsen, J. Dollerup and C.E. Mogensen. -
Aarhus and
Copenhagen, Denmark.
Program number 776 Board# M45 at 10:00 A.M.
Hyperinsulinemia
and circadian variation of blood pressure in essential
hypertension. S. Bianchi, R. Bigazzi, G.
Baldari and V.M. Campese.
- Livorno, Italy and Los Angeles, CA.
Program number 777 Board# M46 at 10:00 A.M.
Salt loading and
hypertension in the elderly.
B.A. Clark, E. Mulkerrin and F.H. Epstein. -
Boston, MA.
Program number 778 Board# M47 at 10:00 A.M.
Supplemental dietary potassium with KHCO3 but not KCl attenuates
essential hypertension.
R.C.
Morris, Jr., M. O'Connor, A.
Forman, R. Peeks and A. Sebastian. - San Francisco,
CA.
Program number 779 Board# M48 at 10:00 A.M.
Arteriosclerosis, not atherosclerosis, is common in end-stage renal
disease: Related
factors. T. Savage, A. Clarke,
M.Giles and A.E.G. Raine. - London, United
Kingdom.
Program number 780 Board# M49 at 10:00 A.M.
Influence
of hypertension and atherosclerosis on arterial distensibility. C.
Spieker,
M.Barenbrock, A.P.G. Hoeks, W. Zidek and K-H. Rahn. -
Munster, Germany
and Maastricht, The Netherlands.
Program number 781 Board# M50 at 10:00 A.M.
Effect
of exogenous insulin on renal urate and sodium handling in normal
subjects. J.C. Ter Maaten,
A. Voorburg, P.M. Ter Wee,
A.J.M. Donker and R.O.B. Gans. - Amsterdam, The
Netherlands.
Program number 785 Board# M54 at 10:00 A.M.
Hyperinsulinemia
and microalbuminuria in never treated essential hypertension patients.
J. Redon, E.
Lurbe, A. Miralles, J.M. Pascua, J. Serrano, R. Garcia-Robles.
- Sagunto,
Valencia and Madrid, Spain.
Program number 786 Board# M55 at 10:00 A.M.
Serum
calcium, the parathyroids and hypertension in the hemodialysis
population. M.M.Salem. -
Jackson, MS.
Program number 787 Board# M56 at 10:00 A.M.
A
family history of hypertension is associated to nephrosclerosis and
predicts the future onset
of hypertension in patients with IGA nephropathy. P. Simon, R.
Boulahrouz, V.
Autuly, C. Charasse and P. Le
Cacheux, K.S. Ang and M.P. Ramee. - St. Brieuc,
France.
Program number 789 Board# M58 at 10:00 A.M.
Diurnal
blood pressure patterns in normotensive and hypertensive children and
adolescents.
C.W. Belsha,
T.G. Wells, J. Plummer and P.L. Berry. - Little
rock, Ar.
9:00 A.M.
---Poster--- San Diego Conv Ctr Halls A and B
Hypertension and
chronic renal failure
Program number 790 Board# M59 at 10:00 A.M.
Outcomes
and risks of renal revascularization in azotemic atherosclerotic
patients. S.C.
Textor, J.W. Hallett, P.B.
Kos, C.L. Schneider, G. Nicpon and A. Schirger. -
Rochester, MN.
Program number 793 Board# M62 at 10:00 A.M.
Attribution of hypertension as the underlying cause of ESRD: Does rACE
matter? N.R. Powe, J.A. Hermann, J.
Coresh, P.W. Whelton and M.J.
Klag. - Baltimore, MD.
Program number 796 Board# M65 at 10:00 A.M.
Nephrosclerosis in the white: No correlation between hypertension and
renal histologic lesions.
A. Meyrier, D. Eladari,
J-J. Montseny, P. Simon and D. Kleinknecht. -
St.-Brieuc, France.
9:00 A.M.
---Poster--- San Diego Conv Ctr Halls A and B
Hemodynamic/cardiovascular relationships of
dialysis/end-stage renal disease
Program number 820 Board# M89 at 10:00 A.M.
Increased interdialytic weight gain is associated with left ventricular
hypertrophy in white
hemodialysis patients. O. Ifudu,
M. Dawood, P. Homel and E.A. Friedman. - Brooklyn,
NY.
Program number 882 Board# M151 at 10:00 A.M.
Changes
in plasma endothelin concentration and hemodynamic parameters during
recombinant human
erythropoietin administration in maintenance hemodialysis patients.
D.H. Kang, K.B. Choi, K.I.
Yoon and D.S. Han. -
Seoul, Korea.
9:00 A.M. ---Poster--- San Diego
Conv Ctr Halls A and B
Clinical manifestations of genetic disease
Program number 1220 Board# M489 at 10:00 A.M.
Rate of
loss of renal function in hypertensive and normotensive autosomal
dominant polycystic kidney
disease patients. A.
Chapman, A. Johnson, P. Gabow and R. Schrier. -
Denver, CO.
Program number 1222 Board# M491 at 10:00 A.M.
Factors affecting renal growth rates in adults with autosomal dominant
polycystic kidney
disease. C. Golin, A. Johnson,
M. Manco-Johnson and P. Gabow. - Denver, CO.
Program number 1225 Board# M494 at 10:00 A.M.
Adequacy
of blood pressure control and renal function in autosomal dominant
polycystic kidney
disease. A.K. Saggar-Malik, K.
Pettitt, G.A. Sagnella, S. Jeffery, s. Morgan, J.B. Eastwood, M.A.
Patton and G.A. MacGregor.
- London, United Kingdom.
9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Vascular
cell structure and signalling
Program number 1291 Board# M560 at 10:00 A.M.
Circulating adhesion molecules in toxemia, gestational hypertension and
normal pregnancy: Evidence
for selective dysregulation of VCAM-1 homeostasis in pre-eclampsia.
J.R. Higgins, A.
Papayianni, H.R. Brady, M. Darling
and J.J. Walshe. - Dublin, Ireland and Boston, MA.
Tue. Nov. 7
1995
9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Hypertension: Basic
Program number 1498 Board# T48 at 10:00 A.M.
Consequences of an altered transport coupling ratio in Na,K-ATPase for
renal sodium reabsorption
and salt-sensitive hypertension. D.E. Orosz and U. Hopfer. -
Cleveland, OH.
Program number 1503 Board# T53 at 10:00 A.M.
Physiologic role of 11-beta-hydroxysteroid dehydrogenase in vascular
smooth muscle.
A.S. Brem,
R.B. Bina, R.R. Warburton, G. Salameh and N.S. Hill. -
Providence, RI.
Program number 1510 Board# T60 at 10:00 A.M.
Examination for
the thiazide-sensitive Na-Cl cotransporter as a candidate gene in
Gordon's syndrome. D.B. Simon,
Z. Farfel, D. Ellison, M. Bia, J. Tucci and R.P. Lifton. -
New Haven, CT.
Program number 1515 Board# T65 at 10:00 A.M.
Sustained systemic arterial hypertension after chronic exposure to
hypobaric hypoxia.
Z.Q. Wang and N.D.
Vaziri. - Irvine, CA.
Program number 1518 Board# T68 at 10:00 A.M.
Contrasting effects of antihypertensive therapy on systemic endothelial
dysfunction and glomerular
injury in salt sensitive hypertension. H. Hayakawa, J. Guerra, K.L.
Coffee and L. Raij.
-
Minneapolis, MN.
9:00 A.M. ---Poster--- San Diego Conv Ctr Halls
A and B
Hypertension:
Clinical II
Program number 1521 Board# T71 at 10:00 A.M.
Do
racial differences exist for early target organ damage in essential
hypertension? R.E. Schmieder,
J.K. Rockstroh and F.H.
Messerli.- Nuremberg and Bonn, Germany and New
Orleans, LA.
Program number 1522 Board# T72 at 10:00 A.M.
Quality
of life in the frican American study of kidney disease and
hypertension pilot study.
J.Y. Lee, D.E.
Smith, C.E. Cornell, M. Faulkner, J. Kopple, J.W. Kusek and S.
Milligan. -
Bethesda, MD.
Program number 1525 Board# T75 at 10:00 A.M.
Nocturnal blood
pressure in treated hypertensive African-Americans compared to treated
hypertensive European Americans.
L.A. Hebert, G. Agarwal, M. Reif, L. Hiremath, S. Carlton, N.S. Nahman,
M.E. Falkenhain and
S.Ladson-Wofford. - Cincinnati and Columbus, OH.
Program number 1527 Board# T77 at 10:00 A.M.
Risk
of drug-induced dyslipidemia on cardiovascular morbidity in the treated
hypertensive
patients.
S.N. Nelluri, A.K. Mandal, H. Saini, M.G. Saklayen and H.J. Khamis.
- Dayton, OH.
Program number 1531 Board# T81 at 10:00 A.M.
Adherence intervention improves outcome of inner city hypertensives.
R. Fong, D. Morisky, C.
Gallop, L. Jones and H. Ward.
- Los Angeles, CA.
Program number 1532 Board# T82 at 10:00 A.M.
Second trimester 24-hour ambulatory blood pressure monitoring: Can it
predict the development
of hypertension in primigravidae.
J.Higgins, M. Darling, A. Halligan, E. O'Brien, R. Conroy and J.
Walshe. -
Dublin,Ireland.
Program number 1534 Board# T84 at 10:00 A.M.
Dissociation of
microalbuminuria and insulin resistance in mild essential
hypertension.
T.G. Jenssen, I. Toft and
K.H. Banaa.- Trondheim, Norway.
Program number 1536 Board# T86 at 10:00 A.M.
Birth
weight and adult hypertension in women. G.C. Curhan, G.M. Chertow,
W.C. Willett and M.J.
Stampfer. -
Boston, MA.
Program number 1537 Board# T87 at 10:00 A.M.
Renal mass
and blood pressure in normal children. P.H. Lane, R.E. Lynch, G.F.
Steinhardt and E.G. Wood.
-
St. Louis, MO.
Program number 1538 Board# T88 at 10:00 A.M.
Captopril
and doxazosin induce similar changes in renal hemodynamics in
hypertensive patients with
insulin dependent diabetes mellitus. E. Svarstad, E. Gerdts, P.
Omvik, B.M.
Iversen J. Ofstad. -
Bergen, Norway.
9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Complications and outcomes in
end-stage renal disease III
Program number 1611 Board# T161 at 10:00 A.M.
Pulmonary hypertension in hemodialysis patients. N. Saffarian, J.
Piriz, F. Visco and M. Dave. -
Bronx, NY.
9:00 A.M. ---Poster--- San Diego Conv
Ctr Halls A and B
Clinical transplantation I
Program number 1813 Board# T363 at 10:00 A.M.
Blood pressure
falls late after liver transplantation despite reduced renal function.
S.J. Taler, S.C.
Textor, V.J. Canzanello, L. Schwartz,
M.K. Porayko, R.H. Wiesner and R.A. Krom. -
Rochester, MN.
4:00 P.M.
---Free Communications--- San Diego Conv Ctr Rm 16a
Hypertension:
Basic
Program number 2081 at 4:00
Prospective screening for
Liddle's syndrome: Genotype-phenotype relationships. J.H. Hansson,
C.
Nelson-Williams, R. Shimkets, J.
Findling, H. Raff, T. Wilson and R.P. Lifton. - New
Haven, CT.
4:00 P.M.
---Free Communications--- San Diego Conv Ctr Rm 5ab
Morbidity and
mortality in end-stage renal
disease patients
Program number 2105 at 4:30
Hypertension, cardiomyopathy,
cardiac morbidity and mortality in ESRD. R.N. Foley, P.S.
Parfrey, J.D. Harnett, G.M. Kent,
D.C.
Murray and P.E. Barre. -
St. John's and Montreal,Canada.
Wed. Nov. 8
1995
10:00 A.M. ---Free
communications--- San Diego Conv Ctr Rm 11a
Hypertension:
Clinical
Program number 2189 at 10:00
Severe autosomal dominant
hypertension and brachydactyly in a unique Turkish kindred maps to
human chromosome 12q13.
F.C. Luft, T.
Wienker, H. Schuster, N.
Bilginturan, H. Toka, S. Bahring, O. Toka, I.Jeschka, D. Gilbert and
H. Haller. -
Berlin, Germany and Ankara, Turkey.
Program number 2190 at 10:15
Deletion polymorphism of the
angiotensin I converting enzymegene is a risk factor for target organ
damage in essential
hypertension. R.
Pontremoli, G.P. Bezante, A. Sofia, A.Tirotta, M. Ravera, C.
Nicolella, F. Viazzi, N. Bobola, R.
Ravazzolo and G. Deferrari. - Genoa, Italy.
Program number 2192 at 10:45
Prolonged treatment with
the renin inhibitor remikiren inhypertensive patients with different
degrees of impaired renal
function. P. Van
Paassen, D. De Zeeuw and P.E. DeJong. - Groningen,
The Netherlands.
Program number 2193 at 11:00
Endogenous erythropoietin
correlates with arterial bloodpressure in essential hypertension.
M.R.W.Langenfeld, G. Rupprecht, H.P. Schobel and R.E.
Schmieder. -
nuremberg,Germany.
Program number 2194 at 11:15
Atrial natriuretic peptide is
reduced both in white and black salt-sensitive hypertensives.
V.M. Campese, S. Bianchi, R. Bigazzi
and L. Raij. -
Los Angeles, Ca andMinneapolis,Mn.
10:00 A.M.
---Free Communications--- San
Diego Conv Ctr Rm 4
Renin angiotensin system: Polymorphism and
renal disease
Program number 2249 at 10:30
The m235t variant of the
angiotensinogen gene and nephropathy in type 2 diabetes.
S. Schmidt, K.
Strojek, W. Grzeszczak, D. Ganten
and E. Ritz. - Heidelberg and berlin, Germany.
Use BACK arrow on your browser (faster) or click
here to go back to ASN95 main page
Click
on ARROW for HDCN Home Page.